Oncology & Cancer

Immunotherapy drug delays recurrence in kidney cancer patients

Treatment with an immunotherapy drug following kidney cancer surgery, prolonged disease-free survival rates in patients at high risk for recurrence, according to an interim report of a phase 3 clinical trial of adjuvant immunotherapy ...

Vaccination

Biden marks vaccine progress, thanks troops ahead of holiday

President Joe Biden started the Memorial Day weekend by visiting a rock climbing gym in northern Virginia as the state lifted all COVID-19 distancing and capacity restrictions at private businesses and much of the nation ...

Diseases, Conditions, Syndromes

India tops 200,000 dead as virus surge breaks health system

India crossed a grim milestone Wednesday of 200,000 people lost to the coronavirus as a devastating surge of new infections tears through dense cities and rural areas alike and overwhelms health care systems on the brink ...

Medications

Tislelizumab plus chemo slows advanced squamous NSCLC

(HealthDay)—For patients with advanced squamous non-small cell lung cancer (sq- NSCLC), adding tislelizumab in combination with chemotherapy is associated with improved progression-free survival (PFS), according to a study ...

page 2 from 36